Anti-FHOD3/ FHOS2/ Formactin2 functional antibody
Anti-FHOD3/ FHOS2/ Formactin2 functional antibody for cell culture, ELISA & in-vivo assay
Go to FHOD3/FHOD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1501-Ab-1/ GM-Tg-hg-SE1501-Ab-2 | Anti-Human FHOD3 monoclonal antibody | Human |
GM-Tg-rg-SE1501-Ab-1/ GM-Tg-rg-SE1501-Ab-2 | Anti-Rat FHOD3 monoclonal antibody | Rat |
GM-Tg-mg-SE1501-Ab-1/ GM-Tg-mg-SE1501-Ab-2 | Anti-Mouse FHOD3 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1501-Ab-1/ GM-Tg-cynog-SE1501-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FHOD3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1501-Ab-1/ GM-Tg-felg-SE1501-Ab-2 | Anti-Feline FHOD3 monoclonal antibody | Feline |
GM-Tg-cang-SE1501-Ab-1/ GM-Tg-cang-SE1501-Ab-2 | Anti-Canine FHOD3 monoclonal antibody | Canine |
GM-Tg-bovg-SE1501-Ab-1/ GM-Tg-bovg-SE1501-Ab-2 | Anti-Bovine FHOD3 monoclonal antibody | Bovine |
GM-Tg-equg-SE1501-Ab-1/ GM-Tg-equg-SE1501-Ab-2 | Anti-Equine FHOD3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1501-Ab-1/ GM-Tg-hg-SE1501-Ab-2; GM-Tg-rg-SE1501-Ab-1/ GM-Tg-rg-SE1501-Ab-2; GM-Tg-mg-SE1501-Ab-1/ GM-Tg-mg-SE1501-Ab-2; GM-Tg-cynog-SE1501-Ab-1/ GM-Tg-cynog-SE1501-Ab-2; GM-Tg-felg-SE1501-Ab-1/ GM-Tg-felg-SE1501-Ab-2; GM-Tg-cang-SE1501-Ab-1/ GM-Tg-cang-SE1501-Ab-2; GM-Tg-bovg-SE1501-Ab-1/ GM-Tg-bovg-SE1501-Ab-2; GM-Tg-equg-SE1501-Ab-1/ GM-Tg-equg-SE1501-Ab-2 |
Products Name | Anti-FHOD3 monoclonal antibody |
Format | mab |
Target Name | FHOD3 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-FHOD3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1501-Ag-1 | Recombinant multi-species FHOD3/ FHOS2/ Formactin2 protein |
Target information
Target ID | GM-SE1501 |
Target Name | FHOD3 |
Gene ID | 80206,225288,100360334,709762,480157,101098341,785433,100067548 |
Gene Symbol and Synonyms | A930009H06Rik,CMH28,FHOD3,FHOS2,Formactin2,mKIAA1695 |
Uniprot Accession | Q2V2M9 |
Uniprot Entry Name | FHOD3_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000134775 |
Target Classification | N/A |
The target: FHOD3, gene name: FHOD3, also named as FHOS2, Formactin2. The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQS™1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.